Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Serina Therapeutics (AMEX:SER), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX), Elicio Therapeutics (NASDAQ:ELTX) and MAIA Biotechnology (AMEX:MAIA).
Kronos Bio has a consensus price target of $7.31.
The stock price for Kronos Bio (NASDAQ: KRON) is $0.9579 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.